These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 20578122)

  • 21. Emergence of Indigenous Artemisinin-Resistant Plasmodium falciparum in Africa.
    Lu F; Culleton R; Zhang M; Ramaprasad A; von Seidlein L; Zhou H; Zhu G; Tang J; Liu Y; Wang W; Cao Y; Xu S; Gu Y; Li J; Zhang C; Gao Q; Menard D; Pain A; Yang H; Zhang Q; Cao J
    N Engl J Med; 2017 Mar; 376(10):991-3. PubMed ID: 28225668
    [No Abstract]   [Full Text] [Related]  

  • 22. pfmdr1 (Plasmodium falciparum multidrug drug resistance gene 1): a pivotal factor in malaria resistance to artemisinin combination therapies.
    Gil JP; Krishna S
    Expert Rev Anti Infect Ther; 2017 Jun; 15(6):527-543. PubMed ID: 28355493
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lack of artemisinin resistance in Plasmodium falciparum in northwest Benin after 10 years of use of artemisinin-based combination therapy.
    Ogouyèmi-Hounto A; Damien G; Deme AB; Ndam NT; Assohou C; Tchonlin D; Mama A; Hounkpe VO; Moutouama JD; Remoué F; Ndiaye D; Gazard DK
    Parasite; 2016; 23():28. PubMed ID: 27443837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Are Artemisinin-Based Combination Therapies For Malaria Beginning To Fail in Africa?
    Rosenthal PJ
    Am J Trop Med Hyg; 2021 Sep; 105(4):857-858. PubMed ID: 34491214
    [No Abstract]   [Full Text] [Related]  

  • 25. Absence of association between polymorphisms in the pfcoronin and pfk13 genes and the presence of Plasmodium falciparum parasites after treatment with artemisinin derivatives in Senegal.
    Delandre O; Daffe SM; Gendrot M; Diallo MN; Madamet M; Kounta MB; Diop MN; Bercion R; Sow A; Ngom PM; Lo G; Benoit N; Amalvict R; Fonta I; Mosnier J; Diawara S; Wade KA; Fall M; Fall KB; Fall B; Pradines B
    Int J Antimicrob Agents; 2020 Dec; 56(6):106190. PubMed ID: 33045351
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Combination therapy as a strategy to prevent antimalarial drug resistance].
    Orjuela P; González I; Osorio L
    Biomedica; 2004 Dec; 24(4):423-37. PubMed ID: 15678806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence of Artemisinin-Resistant Plasmodium falciparum Malaria in Eastern India.
    Das S; Saha B; Hati AK; Roy S
    N Engl J Med; 2018 Nov; 379(20):1962-1964. PubMed ID: 30428283
    [No Abstract]   [Full Text] [Related]  

  • 28. Fighting drug-resistant Plasmodium falciparum: the challenge of artemisinin resistance.
    Wongsrichanalai C; Sibley CH
    Clin Microbiol Infect; 2013 Oct; 19(10):908-16. PubMed ID: 24033691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Plasmodium falciparum resistance to artemisinin-based combination therapies (ACTs): Fears of widespread drug resistance].
    Benoit-Vical F; Paloque L; Augereau JM
    Bull Acad Natl Med; 2016 Mar; 200(3):477-89; discussion 490. PubMed ID: 28644374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel pfkelch13 Gene Polymorphism Associates With Artemisinin Resistance in Eastern India.
    Das S; Manna S; Saha B; Hati AK; Roy S
    Clin Infect Dis; 2019 Sep; 69(7):1144-1152. PubMed ID: 30535043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. How genomics is contributing to the fight against artemisinin-resistant malaria parasites.
    Cravo P; Napolitano H; Culleton R
    Acta Trop; 2015 Aug; 148():1-7. PubMed ID: 25910626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The threat of artemisinin-resistant malaria.
    Dondorp AM; Fairhurst RM; Slutsker L; Macarthur JR; Breman JG; Guerin PJ; Wellems TE; Ringwald P; Newman RD; Plowe CV
    N Engl J Med; 2011 Sep; 365(12):1073-5. PubMed ID: 21992120
    [No Abstract]   [Full Text] [Related]  

  • 33. [Combined antimalarial therapy using artemisinin].
    Majori G
    Parassitologia; 2004 Jun; 46(1-2):85-7. PubMed ID: 15305693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The threat of artemisinin resistant malaria in Southeast Asia.
    Hanboonkunupakarn B; White NJ
    Travel Med Infect Dis; 2016; 14(6):548-550. PubMed ID: 27915001
    [No Abstract]   [Full Text] [Related]  

  • 35. [Towards a better understanding of the molecular mechanisms of P. falciparum resistance to artemisinin].
    Khim N; Witkowski B; Duru V; Ariey F; Mercereau-Puijalon O; Ménard D
    Med Sci (Paris); 2014; 30(8-9):727-9. PubMed ID: 25174743
    [No Abstract]   [Full Text] [Related]  

  • 36. [More artemisinin-resistant malaria in Thailand].
    Holen Ø
    Tidsskr Nor Laegeforen; 2012 May; 132(10):1223. PubMed ID: 22855939
    [No Abstract]   [Full Text] [Related]  

  • 37. [Artemisinin resistance in Plasmodium falciparum: global status and basic research].
    Zhao SM; Wang MY
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2014 Oct; 32(5):380-4. PubMed ID: 25726605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence of artemisinin-resistant malaria in western Cambodia.
    Noedl H; Se Y; Schaecher K; Smith BL; Socheat D; Fukuda MM;
    N Engl J Med; 2008 Dec; 359(24):2619-20. PubMed ID: 19064625
    [No Abstract]   [Full Text] [Related]  

  • 39. How to Contain Artemisinin- and Multidrug-Resistant Falciparum Malaria.
    Dondorp AM; Smithuis FM; Woodrow C; Seidlein LV
    Trends Parasitol; 2017 May; 33(5):353-363. PubMed ID: 28187990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. No Plasmodium falciparum Chloroquine Resistance Transporter and Artemisinin Resistance Mutations, Haiti.
    Vincent JP; Komaki-Yasuda K; Existe AV; Boncy J; Kano S
    Emerg Infect Dis; 2018 Nov; 24(11):2124-2126. PubMed ID: 30334724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.